Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo C Faini

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Immunology Letters|July 1, 2018
A phylogenetic view of the leukocyte ectonucleotidasesEnza Ferrero, Angelo C Faini, Fabio Malavasi
Physiological Reviews|March 31, 2021
CD38 in the age of COVID-19: a medical perspectiveAlberto L Horenstein, Angelo C Faini, Fabio Malavasi
Frontiers in Immunology|May 15, 2026
Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspectiveAlberto L Horenstein, Kristine A Frerichs, Angelo C Faini, et al.
Molecules (Basel, Switzerland)|October 24, 2020
The Circular Life of Human CD38: From Basic Science to Clinics and BackAlberto L Horenstein, Angelo C Faini, Fabio Morandi, et al.
Frontiers in Immunology|February 27, 2025
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospectsAlberto L Horenstein, Angelo C Faini, Fabio Morandi, et al.
Human Antibodies|December 31, 2016
Antibody mimicry, receptors and clinical applicationsAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.
British Journal of Haematology|February 11, 2021
Molecular dynamics of targeting CD38 in multiple myelomaFabio Malavasi, Angelo C Faini, Fabio Morandi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Immunology Letters|July 1, 2018
A phylogenetic view of the leukocyte ectonucleotidasesEnza Ferrero, Angelo C Faini, Fabio Malavasi
Physiological Reviews|March 31, 2021
CD38 in the age of COVID-19: a medical perspectiveAlberto L Horenstein, Angelo C Faini, Fabio Malavasi
Frontiers in Immunology|May 15, 2026
Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspectiveAlberto L Horenstein, Kristine A Frerichs, Angelo C Faini, et al.
Molecules (Basel, Switzerland)|October 24, 2020
The Circular Life of Human CD38: From Basic Science to Clinics and BackAlberto L Horenstein, Angelo C Faini, Fabio Morandi, et al.
Frontiers in Immunology|February 27, 2025
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospectsAlberto L Horenstein, Angelo C Faini, Fabio Morandi, et al.
Human Antibodies|December 31, 2016
Antibody mimicry, receptors and clinical applicationsAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.
British Journal of Haematology|February 11, 2021
Molecular dynamics of targeting CD38 in multiple myelomaFabio Malavasi, Angelo C Faini, Fabio Morandi, et al.
Pageof 1